IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients ; volume:24 ; number:1 ; day:3 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
BMC cancer ; 24, Heft 1 (3.1.2024), 1-10, 12.2024
- Creator
-
Crucitta, Stefania
Pasqualetti, Francesco
Gonnelli, Alessandra
Ruglioni, Martina
Luculli, Giovanna Irene
Cantarella, Martina
Ortenzi, Valerio
Scatena, Cristian
Paiar, Fabiola
Naccarato, Antonio Giuseppe
Danesi, Romano
Del Re, Marzia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-11726-0
- URN
-
urn:nbn:de:101:1-2024031813313450674014
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.04.2025, 8:12 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Crucitta, Stefania
- Pasqualetti, Francesco
- Gonnelli, Alessandra
- Ruglioni, Martina
- Luculli, Giovanna Irene
- Cantarella, Martina
- Ortenzi, Valerio
- Scatena, Cristian
- Paiar, Fabiola
- Naccarato, Antonio Giuseppe
- Danesi, Romano
- Del Re, Marzia
- SpringerLink (Online service)
Other Objects (12)
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Is deoxygenation detectable before warming in the thermocline?
Is deoxygenation detectable before warming in the thermocline?
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Is a social differentiation detectable in the TRB culture?
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Is deoxygenation detectable before warming in the thermocline?
Is deoxygenation detectable before warming in the thermocline?
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Is a social differentiation detectable in the TRB culture?
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition
IDH1 mutation analysis – an example of putative glioma marker
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Is deoxygenation detectable before warming in the thermocline?
Is deoxygenation detectable before warming in the thermocline?
Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma
Is a social differentiation detectable in the TRB culture?
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma